The NET Alliance™ and Novartis Oncology continue their commitment to improving knowledge and management of neuroendocrine tumors, and empowering patients to be more informed advocates.

  • А
  • А
  • А

Pancreatic NET: Uncommon and complex

The endocrine cells of the pancreas are formed into clusters called islets of Langerhans, which make up about 1% to 2% of the total mass of the pancreas.11 The islets of Langerhans produce 3 important hormones: insulin, glucagon, and somatostatin.12 Pancreatic neuroendocrine tumors (NET) arise from these cells.13

Pancreatic NET are a distinct, much less common form of pancreatic cancer and have notably different tumor biology from pancreatic adenocarcinomas.14-16

The median survival for patients with well-differentiated pancreatic NET presenting with distant metastases is 23 months.17

Most pancreatic NET are well-differentiated, grade 1 or grade 2 tumors18,19 but can vary in clinical presentation and aggressiveness.20,21 They can be sporadic or associated with genetic syndromes,20 such as multiple endocrine neoplasia type 1 (MEN-1), von Hippel-Lindau syndrome (VHL), von Recklinghausen disease (neurofibromatosis [NF-1]), and tuberous sclerosis complex (TSC).22

Although most pancreatic NET are nonfunctional, they may be associated with symptoms and syndromes due to the oversecretion of specific hormones.20,21

Click on the graphic to learn more about the different types of pancreatic NET.

Chart showing the Classification of Neuroendocrine Tumors (NETs)

Resource for Nurses: Take the NET Nurse Quiz! 

The NET Nurse Quiz is an interactive quiz to test your knowledge on neuroendocrine tumors and how the disease affects your patients.

Are you ready for the quiz?